Vimarsana
Biggest News Aggregation in the World

Coronavirus Testing Solutions News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Coronavirus Testing Solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Coronavirus Testing Solutions Today - Breaking & Trending Today

Sorrento Completes Acquisition of Virex Health, Will - Vimarsana News

Sorrento Completes Acquisition of Virex Health, Will

Virex Health, Inc. is a Boston, Massachusetts company that has developed a powerful, broadly applicable at-home diagnostic platform (“Virex...

Sorrento Completes Acquisition of Virex Health, Will - Vimarsana News

Sorrento Completes Acquisition of Virex Health, Will

Virex Health, Inc. is a Boston, Massachusetts company that has developed a powerful, broadly applicable at-home diagnostic platform (“Virex...

Continuus Pharmaceuticals To Build In-House Small Molecule Manufacturing Facility In Massachusetts - Vimarsana News

Continuus Pharmaceuticals To Build In-House Small Molecule Manufacturing Facility In Massachusetts

Continuus Pharmaceuticals To Build In-House Small Molecule Manufacturing Facility In Massachusetts DoD/HHS contract will enable onshore production of three vital medicines to treat critically ill patients, including those with COVID-19 Company will build the first GMP-certified end-to-end manufacturing facility using its proprietary technology for the production of small-molecule medicines Woburn, MA /PRNewswire/ - CONTINUUS Pharmaceuticals Inc., an innovator in transforming production of small-molecule pharmaceuticals with its proprietary Integrated Continuous Manufacturing (ICM) technology,...

CONTINUUS Pharmaceuticals Secures $69.3 Million Government Contract to Manufacture Critical Medicines in the U.S. - Vimarsana News

CONTINUUS Pharmaceuticals Secures $69.3 Million Government Contract to Manufacture Critical Medicines in the U.S.

Share this article Share this article WOBURN, Mass., Jan. 21, 2021 /PRNewswire/ -- CONTINUUS Pharmaceuticals Inc., an innovator in transforming production of small-molecule pharmaceuticals with its proprietary Integrated Continuous Manufacturing (ICM) technology, today announced receipt of a $69.3 million U.S. government contract to facilitate domestic production of three vital medicines used to treat critically ill patients, including those with COVID-19. The contract, awarded by the Department of Defense (DoD) in conjunction with the Department of Health and Human Services (HHS), will also ...

Continuus lands $69.3m US drug manufacturing contract - Vimarsana News

Continuus lands $69.3m US drug manufacturing contract

Continuus lands $69.3m US drug manufacturing contract The small-molecule pharmaceuticals manufacturer secured a DoD/HHS government contract to manufacture critical medicines for a range of conditions. Continuus Pharmaceuticals, a firm that uses proprietary integrated continuous manufacturing (ICM) technology to manufacture drugs, has been granted a $69.3m (57 EUR) contract to manufacture three different medicines. The contract, awarded by the US Department of Defense (DoD) and Department of Health and Human Services (HHS), also will be used for construction of the ...